Novel short chain fatty acids restore chloride secretion in cystic fibrosis
- 31 March 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 342 (1) , 245-252
- https://doi.org/10.1016/j.bbrc.2006.01.127
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Pharmacological Approaches to Correcting the Ion Transport Defect in Cystic FibrosisAmerican Journal of Respiratory Medicine, 2003
- Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivoBlood, 2002
- Evidence of CFTR Function in Cystic Fibrosis after Systemic Administration of 4-PhenylbutyrateMolecular Therapy, 2002
- A Pilot Study of the Effect of Gentamicin on Nasal Potential Difference Measurements in Cystic Fibrosis Patients Carrying Stop MutationsAmerican Journal of Respiratory and Critical Care Medicine, 2000
- A Pilot Clinical Trial of Oral Sodium 4-Phenylbutyrate (Buphenyl) in Δ F508-Homozygous Cystic Fibrosis PatientsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.Journal of Clinical Investigation, 1997
- Suppression of a CFTR premature stop mutation in a bronchial epithelial cell lineNature Medicine, 1997
- A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin DisordersNew England Journal of Medicine, 1993
- A Cystic Fibrosis Bronchial Epithelial Cell Line: Immortalization by Adeno-12-SV40 InfectionAmerican Journal of Respiratory Cell and Molecular Biology, 1991
- A simple assay for agonist-regulated Cl and K conductances in salt-secreting epithelial cellsAmerican Journal of Physiology-Cell Physiology, 1990